Article Text

Download PDFPDF
Fingolimod significantly reduces MRI activity in paediatric-onset multiple sclerosis (MS)

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Review of article Arnold DL, Banwell B, Bar-Or A et al. Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: Results from the phase 3 PARADIGMS study. J Neurol Neurosurg Psychiatry. 2020;91:483–92.

  • Twitter @laura24chapman

  • Provenance and peer review Not commissioned; internally peer reviewed.